Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lyra Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LYRA.
You can purchase shares of Lyra Therapeutics (NASDAQ:LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Gelteq (NASDAQ:GELS), 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
Lyra Therapeutics has a consensus price target of $8.38.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.089 last updated April 17, 2025 at 7:37 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q1 earnings are confirmed for Friday, May 2, 2025.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.